Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
The thioredoxin-1 inhibitor 1-methylpropyl 2-imidazolyl disulfide (PX-12) decreases vascular permeability in tumor xenografts monitored by dynamic contrast enhanced magnetic resonance imagingBénédicte F Jordan, Matthew Runquist, Natarajan Raghunand, et al.
Neoplasia (New York, N.Y.)|June 22, 2005
Dynamic contrast-enhanced and diffusion MRI show rapid and dramatic changes in tumor microenvironment in response to inhibition of HIF-1alpha using PX-478Bénédicte F Jordan, Matthew Runquist, Natarajan Raghunand, et al.
Magnetic Resonance in Medicine|July 27, 2007
Response of choline metabolites to docetaxel therapy is quantified in vivo by localized (31)P MRS of human breast cancer xenografts and in vitro by high-resolution (31)P NMR spectroscopy of cell extractsDavid L Morse, Natarajan Raghunand, Pooja Sadarangani, et al.
Translational Oncology|June 9, 2016
Magnetic Resonance Imaging Identifies Differential Response to Pro-Oxidant Chemotherapy in a Xenograft ModelTerry H Landowski, Gerald P Guntle, Dezheng Zhao, et al.
Research Square|September 18, 2023
Tumor Response to Stroma-Modifying Therapy: Magnetic Resonance Imaging Findings in Early-Phase Clinical Trials of Pegvorhyaluronidase alpha (PEGPH20)Andrés M Arias-Lorza, James R Costello, Sunil R Hingorani, et al.
Oncotarget|December 20, 2017
Magnetic resonance imaging of RRx-001 pharmacodynamics in preclinical tumorsNatarajan Raghunand, Jan Scicinski, Gerald P Guntle, et al.
Radiology. Artificial Intelligence|June 20, 2024
Presurgical Upgrade Prediction of DCIS to Invasive Ductal Carcinoma Using Time-dependent Deep Learning Models with DCE MRIJohn D Mayfield, Dana Ataya, Mahmoud Abdalah, et al.
Scientific Reports|May 21, 2024
Magnetic resonance imaging of tumor response to stroma-modifying pegvorhyaluronidase alpha (PEGPH20) therapy in early-phase clinical trialsAndrés M Arias-Lorza, James R Costello, Sunil R Hingorani, et al.
Neoplasia (New York, N.Y.)|May 4, 2002
Early response of prostate carcinoma xenografts to docetaxel chemotherapy monitored with diffusion MRIDominique Jennings, B Nicholas Hatton, Jingyu Guo, et al.
Journal of Medicinal Chemistry|November 15, 2012
Redox-active magnetic resonance imaging contrast agents: studies with thiol-bearing 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetracetic acid derivativesBhumasamudram Jagadish, Gerald P Guntle, Dezheng Zhao, et al.
Pageof 6